Rentokil Initial (RTO) EBIT (2021 - 2025)

Rentokil Initial (RTO) posted quarterly EBIT of $511.0 million for Q4 2025, up 322.17% quarter-over-quarter from -$230.0 million in Q3 2025.

Rentokil Initial (RTO) EBIT (2021 - 2025) Analysis & Trends

Rentokil Initial (RTO) has reported EBIT for 4 consecutive years, with $511.0 million the latest figure, recorded in Q4 2025.

In Q4 2025, EBIT changed N/A year-over-year to $511.0 million; the TTM figure through Dec 2025 stood at $1.5 billion (changed N/A YoY), while the FY2025 annual figure was $1.1 billion, up 51.85% from the prior year.
EBIT rose to $511.0 million in Q4 2025 per RTO's latest filing, from -$230.0 million in the prior quarter.
Across five years, EBIT topped out at $669.7 million in Q4 2022 and bottomed at -$230.0 million in Q3 2025.
Historically, EBIT has averaged $417.8 million across 4 years, with a median of $542.4 million in 2023.
Annual changes were most pronounced in 2022 — EBIT advanced 12.41% — and 2023, when it dropped 19.02%.
Rentokil Initial's EBIT stood at $595.8 million in 2021, then grew by 12.41% to $669.7 million in 2022, then slipped by 19.02% to $542.4 million in 2023, then fell by 5.79% to $511.0 million in 2025.
Business Quant data shows RTO's EBIT at $511.0 million in Q4 2025, -$230.0 million in Q3 2025, and $542.4 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT (Qtr)
1	Cintas	81.69 Bn	81.40 Bn	1.48 Bn	673.04 Mn
2	Relx	64.97 Bn	64.80 Bn	-	-
3	Copart	32.09 Bn	28.74 Bn	732.88 Mn	464.28 Mn
4	Global Payments	24.80 Bn	19.40 Bn	2.03 Bn	337.12 Mn
5	Rb Global	16.24 Bn	15.72 Bn	935.50 Mn	224.80 Mn
6	Aramark	15.68 Bn	15.18 Bn	430.34 Mn	215.59 Mn
7	UL Solutions	15.20 Bn	14.77 Bn	417.00 Mn	150.00 Mn
8	Rentokil Initial	11.80 Bn	9.27 Bn	-	-
9	Dolby Laboratories	6.05 Bn	5.38 Bn	264.68 Mn	34.32 Mn
10	Unifirst	5.23 Bn	5.06 Bn	234.73 Mn	23.03 Mn

Download Data